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Proximal tubular injury in Chinese herbs nephropathy: Monitoring by
neutral endopeptidase enzymuria. Neutral endopeptidase (NEP) is a 94
kDa ectoenzyme of the proximal tubule brush border, physiologically
released into the urine with apical membrane fragments. As proximal
tubular atrophy was a histological hallmark of Chinese herbs nephropathy
(CHN), this study firstly determined renal excretion of NEP in healthy
control subjects (N = 31), in patients with CHN (N = 26) and in women
having consumed Chinese herbs and whose renal function was normal but
running the risk of developing CHN (N = 27). Another patient group
consisted of female patients with glomerular diseases (N = 12). At the
same time, measurements of urinary microproteins (Clara cell protein,
retinol binding protein, j32-microglobulin and a1-microglobulin) were
performed, as indicators of tubular dysfunction. Cell damage was esti-
mated by the excretion of N-acetyl-/3-D-glucosaminidase (NAG). In the
control group, the physiological NEP enzymuria was 43.1 ,tsg/24 hr
(geometric mean). In CHN patients, levels of urinary NEP were signifi-
cantly decreased in those with moderate renal failure (26.7 jrg/24 hr; N =
21; P < 0.05) and almost abolished in end-stage renal failure patients (4.35
sgI24 hr; N = 5; P < 0.05). In patients at risk as well as in patients with
glomerular diseases, urinary NEP levels were not statistically different
from those observed in control subjects (40.68 xg/24 hr and 48.5 .rg/24 hr,
respectively). Several degrees of tubular dysfunction and injury were noted
in patients groups, as attested by increased urinary mieroproteins and
NAG excretions. Considering the data from control and CHN patients,
NEP enzymuria positively correlated with individual creatinine clearance
values (r = 0.76; P = 0.0001) and negatively correlated with urinary
microproteins levels (r = —0.55; P = 0.00001). Finally, NEP was regularly
quantitated in the urine of 6 CHN patients for a period ranging from six
months to two years and in 19 patients at risk during two years,
respectively. In the first group, renal function progressively deteriorated in
3 patients, leading them to renal replacement therapy after 38 to 115
weeks. Stable parameters were observed in the remaining 3 patients. A
direct correlation between creatinine clearance and NEP excretion was
found longitudinally iii each case. In the second group, no significant
change of urinary NEP levels was observed (45,9 g/24 hr), in parallel with
stable renal function. Taken together, these results indicate that, in CHN
patients, NEP enzymuria provides a rapid and noninvasive determination
of the degree of structural impairment affecting the proximal tubular
population and further rc!lecting the severity of the renal disease. The
interest of this urinary marker in monitoring the progression of other
tuhulointerstitial diseases renlains to be assessed.
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Neutral endopeptidase 24.11 (NEP) is a zinc metallopeptidase
anchored to the eel! surface of many tissues [1] and involved in
regulatory processes affecting target cell responses by cleavage of
several peptidic hormones [2, 3]. In the kidney, this ectoenzyme is
abundantly localized on the brush border membranes of the
proximal tubular epithelium, processing filtered peptides present
in the tubular fluid [4]. An excreted form has been identified irs
human urine and is probably kidney-derived [5]. Indeed, the large
size of the soluble plasmatic enzyme ('--'94 kDa) and the low
concentration of this circulating form (—13 ng/ml) [6] permit the
exclusion of the possibility of a significant plasma contribution to
the urinary excretion, suggesting that NEP enzymuria mainly
reflects the amount of the renal enzyme. This was supported by
the recent work of Aviv et al, reporting increased NEP content
both in the kidney and in urine after a chronic salt loading in the
rat [7]. In humans, no data on NEP enzymuria are available,
except transiently increased urinary levels of NEP early after renal
transplantation [8]. These in vivo results are in agreement with
morphological studies performed in experimental models of isch-
emia, demonstrating that the proximal tubular epithelium was a
preferential target of ischemic injury [9—12].
In addition to the complex mechanisms related to hemody-
namic modifications, toxic agents may directly or not damage the
proximal tubule. Numerous studies over the last decades have
pointed out the differences in susceptibility to certain nephrotoxi-
cants of several parts of the ncphron, according to their distinct
morphological, biochemical, and hence, functional properties
[reviewed in 13]. Although physiopathological mechanisms re-
main to be elucidated, an interesting example was provided by the
recently described Chinese herbs nephropathy (CHN) [14]. Cases
of rapidly progressive interstitial renal fibrosis were observed in
Belgium in young female patients and related to a slimming
regimen including Chinese herbs called Stephania tetrandra and
Magnolia officinalis. Phytochemical analyses of batches of the
so-called S tetrandra resulted in the identification in most of the
herbs of aristolochie acids [15], known for their ncphrotoxic
properties [16], instead of the expected tetrandrine. Careful
examination of renal biopsy material from these patients revealed
that the destruction process of the tubules started in the superfi-
cial cortex, mainly composed of proximal tubules, and progressed
towards the deep cortex [17]. Along these lines, we tested the
288
Nortier et al: NEP in Chinese herbs nephropathy 289
hypothesis that NEP enzymuria could contribute to the evaluation
of the severity of this tubulointerstitial nephritis at different stages
of the disease.
The aims of the present study were first to measure NEP
concentration in normal human urine and in urine from patients
with several degrees of renal failure due to CHN. Data were
compared with those obtained from patients having consumed
Chinese herbs and whose renal function was normal, but running
the risk of developing CHN, and from patients with glomerular
diseases. Secondly, we wanted to relate these results with urinary
measurements of well-known markers: N-acetyl-p-D-glucosamini-
dase (NAG) (EC 3.2.1.30), another enzyme of renal origin,
abnormally released from lysosomes into the tubular fluid in case
of intracellular damage [18, 19]. The severity of tubular dysfunc-
tion was investigated by measuring the capacity of proximal
tubular cells to reabsorb filtered microproteins such as Clara cell
protein (CC16; 15.8 kDa), retinol binding protein (RBP; 22.2
kDa), 2-microglobulin (132m; 11.8 kDa) and a1-microglobulin(a1m; 26 to 31 kDa) [20]. Finally, we had the opportunity to
perform a long-term follow-up of 6 CHN patients and 19 patients
running the risk of developing CHN, in order to relate NEP
enzymuria with renal outcome.
Methods
Normal and patient populations
Thirty-one healthy female volunteers from the laboratory staff,
aged 22 to 63 years, previously confirmed to have normal renal
function parameters, were tested for NEP and NAG enzymuria
and for urinary excretion rate of CC16, RBP, 2m and a1m.
The group of CHN patients was composed of 26 female patients
(ages ranging from 33 to 58 years) admitted in the Nephrology
departments of either Erasme Hospital or Institut Medical E.
Cavell, between November 1992 and July 1993. All had followed
a slimming regimen including Chinese herbs (CH) from May 1990
to June 1992. The exposure period of the patients to these
Chinese herbs varied from 4 to 27 months at a dosage of 300 to
900 mg of powder extract per day for the so-called Stephania
tetrandra.
Five out of 26 patients were admitted in end-stage renal failure
(ESRF) requiring immediate hemodialysis. The remaining 21
patients entered for diagnostic management of their renal insuf-
ficiency (including renal biopsy, which was accepted and success-
fully performed for 17 out of 20). None of these patients received
corticoids during the study. Six Out of them were regularly (every
6 week period, approximately) re-evaluated in terms of their
tubular markers in addition to the usual parameters of renal
function. This follow-up period ranged from six months to two
years.
The group of patients running the risk of developing CT-IN was
composed of 27 women who consumed CH during the same
critical period and according to identical oral administration
prescriptions (see above). They consulted us to check on their
renal function. They were informed that serum creatinine level
was normal (between 70 and 105 smo1/liter) and that a follow-up
was advisable. Among them, 22 accepted a one-year follow-up and
19 were still present after two years.
The last group of patients contained 12 patients with different
glomerular diseases, characterized by moderate to severe albu-
minuria (geometric mean 1.1 g/24 hr). Two were in ESRF and the
remaining 10 had different degrees of renal failure. Histological
diagnosis was obtained for 11 out of these patients, the last one
having congenital renal hypoplasia. None of these patients re-
ceived corticotherapy.
Collection of urine and serum samples
Twenty-four-hour urine samples and peripheral venous blood
were collected from normal volunteers and each patient. Each
patient was free of Chinese herbs and other drugs for at least two
months at the moment of the first 24-hour urine collection. For
NEP assay, fresh urine samples were kept at 4°C until the analysis
which was performed in the 72 following hours, taking into
account preliminary stability experiments [211. For other markers,
measurements were performed on urine samples after one freez-
ing-thawing cycle. Because of the stability of the measured
microproteins in acid urines (except jl2m susceptible to be de-
graded by several mechanisms and for which measurements may
be underestimated), no precaution was taken to alkalinize urine
samples during or after collection.
Markers assay methods
Urine and serum creatinine was determined by the Jaffé
reaction and the creatinine clearance was calculated on the basis
of the 24-hour urine collection.
Endopeptidase enzymatic activity was measured by a spec-
trofluorimetric assay [81 after 1/15, 1/30 and 1/60 dilution of the
urine samples with 50 ms'i Tris HCI buffer, pH 7.6. In brief, the
synthetic substrate succinyl-alanyl-alanyl-phenylalanine-7-amido-
4-methyl coumarine (Suc-Ala-Ala-Phe-AMC; Bachem, Buben-
dorf, Switzerland) was cleaved by NEP to produce Phe-AMC.
This compound, after incubation with aminopeptidase M (EC
3.4.11.2; Pierce, Rockford, IL, USA), generates AMC. By the use
of a standard curve established with purified human renal NEP, it
was possible to convert the rate of AMC production into enzyme
amounts.
Urinary levels of CC16 were determined by a sensitive latex
immunoassay relying on the agglutination of latex particles [22].
The same methodology was used for f32m, RBP, a1m and albumin
measurements in urine samples, as previously reported [23]. The
activity of NAG was measured by a fluorimetric assay according to
the method described by Tucker et al [241.
Statistical analysis
Differences between values of tubular markers excretion in
control and patient populations as well as in patient groups were
assessed by one-way analysis of variance followed by the Dunett's
multiple comparison test. Results were reported as statistically
significant at P 0.05. Data on urinary CCI6 protein were log
transformed before statistical analysis, and the normality of all
variables distribution was checked using the Kolmogorov-
Smirnof's one-sample test. Linear regression tests were per-
formed by calculating the correlation coefficient.
Results
NEP enzymuria and other tubular markers in controls and in
patients previously exposed to Chinese herbs
Experimental data obtained at the beginning of the study, from
24-hour urine samples of healthy women and patients having
consumed CH and presenting or not presenting with renal failure,
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Table 1. Experimental data obtained from 24-hr urine samples of healthy women, patients at risk and patients with Chinese herbs nephropathy
Control Patients Patients with End-stage renal
population at risk renal failure failure patients
________ __________
(N = 31) __________(N = 27) (N = 21)
___________
(N = 5)
Creatinine clearance mI/mm" 113 27 98 29 40 14° 8 2°
Albuminuria mg/24 hrF 6.33 7.8 63.9c 543
(1.62—346) (2.33—128) (11.5—444) (13—184)
NEP pg/24 hr1' 43.1 40.68 26.7° 4.35°
(26.7—67.8) (22.7—87.2) (13.5—45.5) (1.1—12.4)
NAG UI/24 hr" 0.68 1.35 2.15° 1.42°
(0.23—2.93) (0.33—3.62) (0.77—6.24) (0.7—2.3)
CCI6 p.g/24 hr' 3.49 10.94" 891° 963°
(0.49—65.4) (0.99—359) (96.4—4,180) (599—2,420)
I32m pg/24 hr5 50.9 82.1 13,970° 38,200°
(0.42—363) (17.5—199) (708—104,400) (15,800—77,400)
RBP p.g/24 hr5 45.2 100 7,760c 47,900°
(1.19—363) (22.2—316) (186—97,400) (18,600—134,000)





a Data arc mean SI)IData are geometric mean with the range between brackets
P < 0.05, compared to control values
are represented in Table 1. Patients at risk, that is, without renal
insufficiency, had urinary levels of markers in the physiological
range, except for CC16 excretion rates which were significantly
higher than the values obtained in the reference female popula-
tion. In CHN patients, the urinary NEP excretion rate was
significantly decreased. This reduction was more pronounced in
ESRF patients than in those with moderate to severe renal
insufficiency, suggesting a progressive atrophy process affecting
the proximal tubular population. As opposed to NEP, other
tubular markers (NAG, CCI6, 2m, RBP and a1m) were mark-
edly increased in urine. This increased excretion of microproteins
was particularly drastic, reaching values more than 1,000 times
above normal, which testifies to a severe proximal tubule function
failure. On the other hand, the increment of albuminuria in the
patient population was not so dramatic, confirming the tubular
rather than glomerular character of proteinuria.
Considering individual results of urinary NEP excretion and
ereatinine clearance measured in all patients and in healthy
subjects, a positive correlation between NEP enzymuria and
ereatinine clearance was observed (r = 0.76, P = 0.0001; Fig. IA).
Significant correlations were also found for urinary mieroproteins
(rvalues ranging from —0.58 to —0.64; P = 0.0001). According to
this and knowing that plasma CC16 protein followed the filtra-
tion-proximal tubular uptake route, it was assumed that various
degrees of proximal tubular dysfunction might be related to the
relative severity of structural impairment reflected by the urinary
release of NEP from the remaining intact brush borders. The
examination of NEP and nhleroproteins measurements (CC16 as
well as f31m, s1m and RUP) performed in the total patient
population and in the control group, indeed revealed that these
urinary markers were negatively correlated (r —0.55, P
0.0001; Fig. I B). By contrast, no significant correlation was found
between NEP and NAG enzymurias (data not shown).
NEP enzymuria and other tubular markers in patients with
glomerular diseases
Table 2 summarizes the results obtained in the patient group
with glomerular diseases. Several types of glomerulonephritis
were investigated, at different stage of renal failure (mean creat-
me clearance SD, 43.8 24.7 ml/min). Proteinuria of glomer-
ular type was present, as attested by significative albuminuria
(geometric mean 1.1 g/24 hr). A marked discrepancy was observed
in NEP values, ranging from 27.9 to 177.8 j.tg/24 hours (geometric
mean 48.5 j.rg/24 hr, not statistically significant from the control
population). High levels of urinary microproteins and NAG
compatible with tubular impairment versus damage were noted.
No significant correlation was found between NEP enzymuria and
creatinine clearance or albuminuria (data not shown).
Anatomopathological analysis in patients with CHN
As indicated in the Methods section, renal tissue was success-
fully obtained in 17 out of 20 women admitted for renal failure.
Renal biopsies of 15 out of these 17 patients are described in
detail in Reference 4. For the purpose of the present study, the
percentage of tubules remaining intact was estimated from the
cortex surface area occupied by apparently unatrophied and
uninjured tubules. Four patients had more than 95% of the
tubules remaining intact (group A) and 3 patients had less than
5% of the tubules remaining intact (group B). Comparing group
B to group A, creatinine clearance was significantly lower
(mean SD, 30 3 vs. 53 15 mI/mm; P < 0.05) as well as NEP
urinary excretion (mean SD, 18.0 5.3 vs. 30.5 12.5 ,itg/24 hr;
P < 0.05). For the 10 patients with a percentage of the tubules
remaining intact estimated around 20 to 50%, the imprecise
nature of this estimation led to a poor correlation with NEP
excretion (creatinine clearance 37 10 mI/mm and NEP urinary
excretion 29.8 8.0 j.tg/24 hr).
Prospective studies on patients exposed to Chinese herbs
Tn 6 CHN patients, NEP and NAG enzymurias as well as
urinary microproteins were assayed for a follow-up period ranging
from six months to two years. Individual data for creatinine
clearance and urinary NEP excretion are represented in Figure 2.
In 3 patients, renal function progressively deteriorated, reaching
the end-stage renal failure after 38 to 115 weeks, respectively (Fig.
2A). Urinary NEP levels fell in parallel with the decrement of
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creatinine clearance (Fig. 2B). In the remaining 3 patients, both
renal function parameters and urinaly NEP remained stable. Such
a longitudinal correlation between creatinine clearance and NEP
enzymuria could not he found for any other marker tested (data
not shown).
In the group of at risk patients, urinary NEP and CC16 levels
were regularly quantitated during one year (N = 22) or two years
(N = 19), in parallel with usual parameters of renal function. No
significant change of urinary NEP levels was observed after one
year (geometric mean 37.1 .tgJ24 hr, range 22.3 to 66.6) or two
years of follow-up (45.9, 33.8 to 97.9; Fig. 3A). Urinary CCI6
levels, slightly elevated at time 0 of the follow-up and after one
year (geometric mean 9.8 g/24 hr, 0.6 to 112.5), significantly
decreased after two years, reaching the normal range (2.9, 0.58 to
71.3; Fig. 3B). Serum creatinine remained stable, whereas de-
creased individual values of creatinine clearance were noted.
Follow-up period, weeks
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Fig. 2. Time-courses of creatinine clearance (A,) and urinaty NEP excretion
(B) in 6 patients with CHN. Three subjects (I, •, A) were submitted to
hemodialysis treatment at the end of the follow-up, while the remaining 3
patients (, 0, A) kept stable parameters.
Mean (± SD) creatinine clearance was 87 23 ml/min after one
year and 85 23 mI/mm after two years of follow-up (Fig. 3C),
which was not statistically different from values obtained at the
beginning of the follow-up (98 29 mI/mm).
Discussion
Our results provide evidence that, in CHN, the histologically-
proven atrophy process affecting the proximal tubular population
is quantitatively reflected by a progressive decrease in urinary
NEP levels. The correlation of NEP with creatinine clearance is
not reproduced in glomerular diseases. The usefulness of NEP
enzymuria in monitoring the proximal tubular injury in other
tuhulointerstitial diseases remains to be assessed.
This is the first study to report a long-term follow-up of the
structural and functional defects of the proximal tubular epithe-
hum in patients having consumed CH. According to previous
studies about ultrastruetural localization of NEP in the kidney and
its identification in human urine [4, 51, the amount of urinary NEP
actually reflected the proportion of brush borders remaining
intact at the apical side of the proximal tubules. In CHN patients,
significantly decreased urinary excretion rates of NEP were found,
showing quantitative evidence of the structural impairment of the
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Urinary NEP excretion, ,ig/24 hr
Fig. 1. Cross-sectional correlations between (A urinary NEP excretion and
creatinine clearance (y = 0.29x + 14.35; P = 0.0001; r 0.76) or (B) urinaly
CCI6 excretion (y —0.05x + 3.14; P = 0.0001; r = —0.55) in 26 patients
with CHN, 27 patienis at risk, and in 13 healthy subjects.
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1 Diabetic GS 29 0.02 98 3.52 80.3 5034
2 Diabetic GS 10 1.14 19.2 3.97 1290 68200
3 Diabetic GS 11 2.18 37.7 5.63 1590 152000
4 Membranous GN 42 0.3 36.9 1.42 22.4 47.7
5 Mcmbranous GN 25 4.0 41.5 4.52 145 6690
6 SLE 21 1.1 27.9 2.63 250 3590
7 Membranoproliferative GN (II) 74 9.6 178 17.7 290 1680
8 Focal segmental GN 22 1.21 45 6.51 697 31970
9 Focal segmental GN 65 3.5 50.8 3.31 33.3 2709
10 Focal segmental GN 95 0.96 33.5 2.17 45.4 133
11 IgA GN 89 0.5 70.2 1.50 83.3 152
12 — 42 1.48 58.7 3.44 173 740














biopsies. However, to firmly establish that NEP was a marker of A
the proximal tubular mass, careful histomorphometric measure-
ments of this proximal tubular mass should have been done on
100
.
renal biopsy specimens and correlated with respective urinary
NEP levels. Such histological experiments (that is, specific stain-
ing with antibodies against brush border antigens) could not be
performed for technical and ethical reasons. Indeed, prospective
correlations would also be necessary, requiring repetitive renal










In parallel with the loss of integrity of the apical membrane
domain reflected by decreased NEP enzymuria, functional reper-
cussions of brush border alterations were documented by abnor-




and a1m), revealing severe reabsorptive defects at the luminal
side of the tubule. Such a typical pattern of tubular proteinuria
was previously detailed by Kabanda et al in CHN patients,
showing that this proteinuria was independent of glomerular







ratio of urinary CC16 or RBP over albuminuria in our CHN
patients than in patients with glomerular diseases (data not '
.
_U
shown). In this latter group, whereas signs of tubular dysfunction
were attested by increased urinary microproteins levels, NEP
enzymuria remained in the normal range or increased. Although
the size and the heterogeneity of this group make a clear-cut
interpretation of the data difficult, several underlying mechanisms
might explain these results. First, no extensive lesion of tubular
atrophy was seen on histological preparations of renal tissue
specimen. Even if they were present in other parts of the cortex,
cellular adaptation processes might take place in remnant










might occur. This tubular hypermetabolism process was reported
by Scherberich et al on the basis of histochemical evaluation of
kidney sections of hemodialyzed patients and of increased urinary
0
excretion of angiotensinase A 26J. The authors hypothesized that
kidney tissue proteinuria derived not only from tubulointerstitial Follow-up period, years
involvement of the disease, hut also from synthesis of structural
proteins by remnant nephrons. The progressive loss of this Fig. 3. Urinaiy excretion of NEP (A) and CC/6 (B) and correspondingcreatinine clearance values (C) recorded in patients at risk to develop CHN,
balance could lead to the worsening of the renal disease. Our data at admission time and after one and two years of Jbiiow-up. Horizontal bars
from ESRF patients (patients 2 and 3) and from patients with indicate the geometric (A, B) and arithmetic means (C), respectively.
severe renal failure (creatinine clearance ranging from 20 to 40
mI/mm) excreting significant amounts of NEP support this hy- patients, we investigated the importance of this reduction in terms
pothesis. of renal function. Despite the lack of predictive value of urinary
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longitudinally studied (Fig. 2), NEP levels paralleled the creati-
nine clearance values. At this point it may be important to refer to
the histological study of Depierreux et al on renal biopsy speci-
mens from CHN patients [17]. In their work, the authors were not
able to find a significant correlation between the renal function
and the severity of the histologic changes at the time of the renal
biopsy (based on the chronic interstitial score calculated as the
sum of the score for tubular atrophy and the score for interstitial
fibrosis). However, the patients with more severe lesions found in
the biopsy had a rapid and poor evolution of the renal disease.
From these observations and our data demonstrating a clear cut
correlation between NEP enzymuria and the decline of creatinine
clearance, we can reasonably conclude that a progressive time-
dependent atrophy process affecting the proximal tubular com-
partment represents the major factor of the decline of renal
function in CHN. This is actually in agreement with Fine et al's
pathophysiological hypothesis suggesting that the final common
pathway for progressive loss of renal function could be a chronic
injury of the tubular epithelium, whatever the prior events (wheth-
er from vascular, tubular or glomerular origin) [27].
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